Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

GTx

ClinicalTrials.gov Identifier:

NCT01355484

First received: May 12, 2011

Last updated: June 18, 2014

Last verified: June 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2014
Primary Completion Date:	May 2013 (Final data collection date for primary outcome measure)